Hypercoagulability risk factors associated with venous thromboembolic events in patients with idiopathic membranous nephropathy and nephrotic syndrome: a prospective observational study

1. Llach F: Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985; 28:429.10.1038/ki.1985.149Search in Google Scholar

2. Singhal R, Brimble KS: Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006; 118:397.10.1016/j.thromres.2005.03.030Search in Google Scholar

3. Wei LQ, Rong ZK, Gui L, Shan RD: CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr. 1991; 15:454.10.1097/00004728-199105000-00020Search in Google Scholar

4. Llach F, Papper S, Massry SG: The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med. 1980; 69:819.10.1016/S0002-9343(80)80006-4Search in Google Scholar

5. Wagoner RD, Stanson AW, Holley KE, Winter CS: Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int. 1983; 23:368.10.1038/ki.1983.286842962Search in Google Scholar

6. Sarasin FP, Schifferli JA: Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int. 1994; 45:578.10.1038/ki.1994.758164448Search in Google Scholar

7. Robert A, Olmer M, Sampol J, Gugliotta JE, Casanova P: Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int. 1987; 31:830 - 5.10.1038/ki.1987.732437353Search in Google Scholar

8. Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich NA, Nachman PH et al: Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012; 81:190.10.1038/ki.2011.31221918501Search in Google Scholar

9. Lionaki S, Derebail VK, Hogan SL, Barbour SJ, Lee T, Hladunewich NA et al: Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012; 7:43.10.2215/CJN.04250511326533822076873Search in Google Scholar

10. Levey AS, Greene T, Kusek JW, Beck GJ, MDRD Study Group: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol., 2000, 11:A0828.Search in Google Scholar

11. Andrassy K, Ritz E, Bommer J: Hypercoagulability in the nephrotic syndrome. Klin Wochenschr. 1980; 58:1029-36.10.1007/BF014768737005524Search in Google Scholar

12. Cameron JS. The nephrotic syndrome and its complications. Am. J. Kidney Dis. 1987 Sep;10(3):157-71.10.1016/S0272-6386(87)80170-1Search in Google Scholar

13. Di Nisio M, Squizzato A, Rutjes AW, Buller HR, Zwinderman AH, Bossuyt PM: Diagnostic accuracy of Ddimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost 2007; 5: 296 -304.10.1111/j.1538-7836.2007.02328.xSearch in Google Scholar

14. Mannucci PM, Valsecchi C, Bottasso B, D’Angelo A, Casati S, Ponticelli C: High plasma levels of protein C activity and antigen in the nephritic syndrome. Thromb Haemost 1986; 55(1): 31-33.10.1055/s-0038-1661440Search in Google Scholar

15. Haifeng Wu, Birmingham DJ, Rovin B, Hackshaw KV, Haddad N, Haden D et al: D-Dimer level and the risk for thrombosis in systemic lupus erythematosus.Clin J Am Soc Nephrol. 2008; 3: 1628-1636.10.2215/CJN.01480308Search in Google Scholar

16. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L et al: High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117:224.10.1161/CIRCULATIONAHA.107.716951Search in Google Scholar

17. Glassock RJ: Prophylactic Anticoagulation in Nephrotic Syndrome: A Clinical Conundrum. J Am Soc Nephrol. 2007;18: 2221-2225.10.1681/ASN.2006111300Search in Google Scholar

18. Kauffrnann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA: Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med. 1978;65:607-13.10.1016/0002-9343(78)90848-3Search in Google Scholar

19. Boneu B, Bouissou F, Abbal M, Sie P, Caranobe C, Barthe P: Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Thromb Haemost. 1981;46:623-5.10.1055/s-0038-1653432Search in Google Scholar

20. Chemg SC, Huang WS, Wang YF, Yang SP, Lin YF: The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med 2000; 25:167- 72.10.1097/00003072-200003000-0000110698409Search in Google Scholar

21. Citak A, Emre S, Sairin A, Bilge I, Nayir A: Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 2000;14:138- 42.10.1007/s00467005002910684364Search in Google Scholar

22. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH: Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994; 124(1):118-124.Search in Google Scholar

23. Hamano K, Iwano M, Akai Y, Sato H, Kubo A, Nishitani Y et al: Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis 2002; 39:695- 705.10.1053/ajkd.2002.3198611920334Search in Google Scholar